[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368548-105":59,"doc-detail-368548-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","volumetric-nanodroplet-enhanced-ultrasound-surgery-combined-with-immune-checkpoint-inhibition-as-a-cancer-therapy-platform","Volumetric Nanodroplet-Enhanced Ultrasound Surgery Combined with Immune Checkpoint Inhibition as a Cancer Therapy Platform","","Immune checkpoint inhibitors show promise for cancer immunotherapy, but solid tumors often limit efficacy due to an unfavorable tumor microenvironment and insufficient immune cell infiltration. This study enhances immunotherapy by combining anti–PD-1 checkpoint inhibition with nanodroplet-mediated histotripsy. Systemically injected nanodroplets accumulate in tumors, then are activated into cavitating gas bubbles using a rotating imaging probe and low-frequency ultrasound. The treatment induces tumor fractionation, extensive tumor lesions, reduced tumor growth, and increased F4/80+ macrophages and CD8+ T cells, shifting the microenvironment from “cold” to “hot.”",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/volumetric-nanodroplet-enhanced-ultrasound-surgery-combined-with-immune-checkpoint-inhibition-as-a-cancer-therapy-platform/368548/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/volumetric-nanodroplet-enhanced-ultrasound-surgery-combined-with-immune-checkpoint-inhibition-as-a-cancer-therapy-platform/368548.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the treatment combine nanodroplets, ultrasound, and anti–PD-1 therapy?","Question",{"text":112,"@type":113},"Nanodroplets are injected systemically and accumulate in tumors. They are then activated into cavitating gas bubbles with a rotating imaging probe and low-frequency ultrasound, while anti–PD-1 checkpoint inhibition is used to boost immune activity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the purpose of tumor fractionation in this platform?",{"text":117,"@type":113},"Tumor fractionation disrupts the tumor microenvironment so it can shift from a “cold” state to a “hot” state, supporting immune cell infiltration and activation.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune changes were observed after treatment?",{"text":121,"@type":113},"Immunohistochemistry shows increased F4/80+ macrophages and CD8+ T cells in treated tumors. F4/80+ macrophages reached 21.36% ± 3.4%, and CD8+ T-cell recruitment reached 6.76% ± 4.5%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368548,1790240232,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","RESEARCH ARTICLE  \n[www.small-journal.com](www.small-journal.com)  \nVolumetric Nanodroplet-Enhanced Ultrasound Surgery Combined with Immune Checkpoint Inhibition as a Cancer Therapy Platform  \nBar Glickstein, Mike Bismuth, Roni Gattegno, Tiran Bercovici, Oz Shaul,  \nRamona Aronovich, Galit Horn, Anat Globerson Levin, Yi Feng, and Tali Ilovitsh*  \nImmune checkpoint inhibitors hold promise, yet their eﬃcacy in solid tumors is limited by the complex tumor microenvironment and the lack of immune cell inﬁltration. This study aims to enhance immunotherapy by combining anti PD-1 checkpoint inhibition therapy with nanodroplet-mediated histotripsy. The proposed method involves systemic injection of nanodroplets, which accumulate within tumors. These nanodroplets are then activated into cavitating gas bubbles using a rotating imaging probe, followed by low-frequency ultrasound application. This process induces tumor fractionation, facilitating the shift of the tumor microenvironment from cold to hot. Tumor ablation results show extensive lesions  \nwithin the cancerous tissues, demonstrating the eﬀectiveness of the ablation treatment. The combined approach of nanodroplets, ultrasound and anti PD-1 yielded a signiﬁcant reduction in tumor growth compared to control groups. Immunohistochemistry analysis reveals an increase in F4/80+ macrophages and CD8+ T cells in the treated tumor group, indicating an enhanced immune response. F4/80+ macrophages reached 21.36% ± 3.4%, while CD8+ T-cell recruitment achieved 6.76% ± 4.5%, representing a 6.8-anda 5.5-fold increase compared to the control group, respectively. This approach demonstrates the potential to overcome key barriers in solid tumor treatment by combining precise mechanical disruption with systemic immune activation.  \n1. Introduction  \nThe advent of immune checkpoint inhibitors has emerged as a promising immunotherapy strategy for cancer treatment, successfully generating an immune response against cancer cells. [1–3] A primary inhibitory mechanism is the PD-1/PDL1 pathway.[4] PD-1, a checkpoint protein, present on the surface of T cells, inhibits T cell activation and proliferation when engaged by its ligand, PD-L1, found on normal and tumor cells. [5] This interaction is crucial for maintaining immune homeostasis and preventing autoimmunity.[6] Yet, this protective mechanism is exploited in tumor cells, providing an immune escape mechanism that contributes to tumor growth and metastasis. [7,8] By using inhibitors that disrupt the PD-1/PD-L1 interaction and negating the inhibitory signal induced by this binding, T cell activation is no longer suppressed, enabling the immune system to target and ﬁght cancer cells. [9,10] However, the success of these  \nB. Glickstein, M. Bismuth, R. Gattegno, T. Bercovici, R. Aronovich,  \nT. Ilovitsh  \nDepartment of Biomedical Engineering Tel Aviv University  \nTel Aviv 6997801, Israel  \nE-mail: [ilovitsh@tauex.tau.ac.il](ilovitsh@tauex.tau.ac.il)  \n[R. Gattegno](R. Gattegno), [T](T). Ilovitsh TheSagol School of Neuroscience Tel Aviv University  \nTel Aviv 6997801, Israel  \nThe ORCID identiﬁcation number(s) for the author(s) of this article can be found under [https://doi.org/10.1002/smll.202411474](https://doi.org/10.1002/smll.202411474)  \n© 2025 The Author(s) . Small published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modiﬁcations or adaptations are made.  \nDOI: 10.1002/smll.202411474  \nO. Shaul  \nSchool of Electrical Engineering Tel Aviv University  \nTel Aviv 6997801, Israel  \nG. Horn, A. G. Levin  \nImmunology and Advanced CAR-T Cell Therapy Laboratory Research & Development Department  \nTel-Aviv Sourasky Medical Center Tel Aviv University  \nTel Aviv 6423906, Israel  \nA. G. Levin  \nDotan Center for Advanced Therapies Tel-Aviv Sourasky M","cbCaisBlN2O502vX","https://ap.wps.com/l/cbCaisBlN2O502vX","pdf",2741404,14,"English","# Introduction\n## PD-1/PD-L1 checkpoint inhibition and tumor immune evasion\n## Histotripsy-based ultrasound ablation\n## Limitations of histotripsy pressure and focusing\n## Microbubble and nanodroplet strategies","[{\"question\":\"How does the treatment combine nanodroplets, ultrasound, and anti–PD-1 therapy?\",\"answer\":\"Nanodroplets are injected systemically and accumulate in tumors. They are then activated into cavitating gas bubbles with a rotating imaging probe and low-frequency ultrasound, while anti–PD-1 checkpoint inhibition is used to boost immune activity.\"},{\"question\":\"What is the purpose of tumor fractionation in this platform?\",\"answer\":\"Tumor fractionation disrupts the tumor microenvironment so it can shift from a “cold” state to a “hot” state, supporting immune cell infiltration and activation.\"},{\"question\":\"What immune changes were observed after treatment?\",\"answer\":\"Immunohistochemistry shows increased F4/80+ macrophages and CD8+ T cells in treated tumors. F4/80+ macrophages reached 21.36% ± 3.4%, and CD8+ T-cell recruitment reached 6.76% ± 4.5%.\"}]","Volumetric Nanodroplet-Enhanced Ultrasound Surgery Combined with Immune Checkpoint Inhibition as a Cancer Therapy Platform | PDF",1790177458,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1918b12b55ae56ba6739cf93d151dad9.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd74040291ff30008cb50fefb8edb2ea.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ce0b4581a327cdc570516b2253f7194.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c38bf5502a4854aa3e2bd15d7cfa3a2.webp",980,1287]